Document is current
Any future updates will be listed below
-
Authors
Berezhnoy, Georgy
Bae, Gyuntae
Wüst, Leonie
Schulte, Claudia
Cannet, Claire
Wurster, Isabel
Zimmermann, Milan
Jäck, Alexander
Spruth, Eike Jakob
Hellmann-Regen, Julian
Roeske, Sandra
Pürner, Dominik
Glanz, Wenzel
Maass, Fabian
Hufschmidt, Felix
Kilimann, Ingo
Dinter, Elisabeth
Kimmich, Okka
Gamez, Anna
Levin, Johannes
Priller, Josef
Peters, Oliver
Wagner, Michael
Storch, Alexander
Lingor, Paul
Düzel, Emrah
van Riesen, Christoph
Wüllner, Ullrich
Teipel, Stefan
Falkenburger, Björn
Bähr, Mathias
Zerr, Inga
Petzold, Gabor C.
Spottke, Annika
Rizzu, Patricia
Brosseron, Frederic
Schäfer, Hartmut
Gasser, Thomas
Trautwein, Christoph
-
Funding
Funding for this research was provided by:
Universitätsklinikum Tübingen
- License Information
-
More Information
Article History
Received: 31 January 2025
Accepted: 6 May 2025
First Online: 22 May 2025
Declarations
:
: GeB and CT report a research grant by Bruker BioSpin GmbH & Co. KG. CW and HS are employed at Bruker BioSpin GmbH & Co. KG, Ettlingen, Germany. All other authors declare no competing interests.
: The project was carried out in compliance with the Helsinki Declaration, and all participants provided written informed consent. Sample collection and study design were approved by the local Ethics Committee of Eberhard Karls University of Tübingen (ethics numbers 226/2021B02 and 199/2011BO1), Germany. Regarding the Cohort 2 of the present study, the following ethic numbers are of reference – numbers 311/14 (status year 2021) and 312/14 (status year 2018). Harmonized voting was carried out at the Lead Ethics Bonn.
: The data were provided by the study group of DESCRIBE and DANCER studies of the clinical research of the German Center for Neurodegenerative Diseases (DZNE). And data were provided by the study groups of TUEPAC study at the University Hospital of Tuebingen. The clinical data supporting the findings are available upon request to: thomas.gasser@uni-tuebingen.de.
